Anthony Estrada,Alan G Olivero,Snahel Patel,Michael Siu,Joseph Lyssikatos
申请号：
US15041375
公开号：
US10028954B2
申请日:
2016.02.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.
